These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 7720851)
1. The contraceptive implant and the injectable: a comparison of costs. Westfall JM; Main DS Fam Plann Perspect; 1995; 27(1):34-6. PubMed ID: 7720851 [TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of levonorgestrel subdermal implants. Comparison with other contraceptive methods available in the United States. Ashraf T; Arnold SB; Maxfield M J Reprod Med; 1994 Oct; 39(10):791-8. PubMed ID: 7837126 [TBL] [Abstract][Full Text] [Related]
3. Relative cost effectiveness of Depo-Provera, Implanon, and Mirena in reversible long-term hormonal contraception in the UK. Varney SJ; Guest JF Pharmacoeconomics; 2004; 22(17):1141-51. PubMed ID: 15612832 [TBL] [Abstract][Full Text] [Related]
7. Public funding and policies for provision of the contraceptive implant, fiscal year 1992. Kaeser L Fam Plann Perspect; 1994; 26(1):11-6. PubMed ID: 8174690 [TBL] [Abstract][Full Text] [Related]
8. Recent experience with and future directions of contraceptive implants and injectable contraceptives. Alvarez-Sanchez F; Brache V; Faundes A Curr Opin Obstet Gynecol; 1993 Dec; 5(6):805-14. PubMed ID: 8286694 [TBL] [Abstract][Full Text] [Related]
9. Questions of balance: issues emerging from the introduction of the hormonal implant. Forrest JD; Kaeser L Fam Plann Perspect; 1993; 25(3):127-32. PubMed ID: 8354378 [TBL] [Abstract][Full Text] [Related]
10. Long-acting hormonal contraception: assessing impact on bone density, weight, and mood. Kaunitz AM Int J Fertil Womens Med; 1999; 44(2):110-7. PubMed ID: 10338269 [TBL] [Abstract][Full Text] [Related]
11. Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant. Harel Z; Biro FM; Kollar LM; Rauh JL J Adolesc Health; 1996 Aug; 19(2):118-23. PubMed ID: 8863083 [TBL] [Abstract][Full Text] [Related]
12. Birth control for new parents. Jimenez SL Am Baby; 1994 Sep; 56(9):64-6, 83. PubMed ID: 12290891 [TBL] [Abstract][Full Text] [Related]
13. Clinics: Norplant cost chokes services. Family Plan World; 1993; 3(5):1, 28. PubMed ID: 12319135 [TBL] [Abstract][Full Text] [Related]
14. Depo Provera. Position paper on clinical use, effectiveness and side effects. Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658 [TBL] [Abstract][Full Text] [Related]
15. The introduction of a new contraceptive; two years experience with Norplant. Davie J; Hiremath K; Glasier A Health Bull (Edinb); 1996 Jul; 54(4):314-7. PubMed ID: 8783485 [TBL] [Abstract][Full Text] [Related]
16. Norplant may be too costly for low income women. Family Plan World; 1991; ():7, 14. PubMed ID: 12346943 [TBL] [Abstract][Full Text] [Related]
17. The use of Norplant and Depo Provera in adolescents. Ammerman SD J Adolesc Health; 1995 May; 16(5):343-6. PubMed ID: 7662681 [TBL] [Abstract][Full Text] [Related]
18. A comparison of levonorgestrel implants with depo-medroxyprogesterone acetate injections for contraception. London RS J SOGC; 1993 Oct; 15(8):925-8, 32. PubMed ID: 12318530 [TBL] [Abstract][Full Text] [Related]
19. Norplant contraceptive maker accused of profiteering on drug. Sun; 1993 Nov; ():13A. PubMed ID: 12287220 [TBL] [Abstract][Full Text] [Related]
20. Acceptability and discontinuation of Depo-Provera, IUCD and combined pill in Kenya. Sekadde-Kigondu C; Mwathe EG; Ruminjo JK; Nichols D; Katz K; Jessencky K; Liku J East Afr Med J; 1996 Dec; 73(12):786-94. PubMed ID: 9103686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]